BioMarin (BMRN) files a 6.5M share secondary offering. BofA Merrill Lynch and Barclays will act...

|About: BioMarin Pharmaceutical Inc. (BMRN)|By:, SA News Editor

BioMarin (BMRN) files a 6.5M share secondary offering. BofA Merrill Lynch and Barclays will act as joint book running managers.